Bought
Maintained
Sold
Other funds holding XYL
Amundi's XYL Position: Q2 2026 in Review
Amundi reduced its Xylem (XYL) stake by 2.4% in Q2 2026, selling an estimated $14.3M and leaving 5,105,298 shares worth $604M. The position accounts for 0.15% of the portfolio, ranked #123.
Amundi first reported a position in XYL in Q2 2021 and has held it in 21 quarters since. The position peaked at $739M in Q3 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Amundi held 5,105,298 shares of Xylem worth $604M as of Q2 2026.
- Amundi sold 123,627 Xylem shares in Q2 2026, an estimated $14.3M.
- Xylem made up 0.15% of Amundi's portfolio in Q2 2026, its #123 holding.
- Amundi first reported a position in Xylem in Q2 2021 and has held it in 21 quarters since.
- Amundi's Xylem position peaked at $739M in Q3 2025.
- 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.